Matches in Wikidata for { <http://www.wikidata.org/entity/Q60211784> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q60211784 description "article scientifique publié en 2018" @default.
- Q60211784 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q60211784 description "im Juli 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q60211784 description "scientific article published on 03 July 2018" @default.
- Q60211784 description "wetenschappelijk artikel" @default.
- Q60211784 description "наукова стаття, опублікована в липні 2018" @default.
- Q60211784 name "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 name "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 type Item @default.
- Q60211784 label "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 label "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 prefLabel "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 prefLabel "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 P1433 Q60211784-3DA579AE-4A9C-4EB7-92D9-5F86B432A510 @default.
- Q60211784 P1476 Q60211784-D16CAE73-1015-4652-A29D-7585F999C331 @default.
- Q60211784 P2093 Q60211784-CB989605-053D-424E-9304-506A06D24D87 @default.
- Q60211784 P2093 Q60211784-D0C5E255-B1AF-46F3-9477-2BF264FAE63E @default.
- Q60211784 P2093 Q60211784-F4E3AAE6-122E-43C4-8723-C1C7A6515F2D @default.
- Q60211784 P2093 Q60211784-F60DE788-7A08-4A53-AEBA-30F963942678 @default.
- Q60211784 P2860 Q60211784-72097280-94FA-4FB6-98F1-58CE7D89840C @default.
- Q60211784 P2860 Q60211784-C2D43A64-3740-4D6D-82E0-23EE5930CC3C @default.
- Q60211784 P2860 Q60211784-E02F4915-9543-44CE-B9A2-84C439F73EA4 @default.
- Q60211784 P304 Q60211784-91D20A7A-4FD0-40AA-8944-A79A0BB148BA @default.
- Q60211784 P31 Q60211784-D82D5934-FC92-4229-884D-A0C8A88A9B86 @default.
- Q60211784 P356 Q60211784-F5F81152-0C8D-4CD5-BD2C-BBBB2A45186D @default.
- Q60211784 P433 Q60211784-F5A27766-B7DF-42E0-A02E-C79A02F5F7AB @default.
- Q60211784 P478 Q60211784-DF336458-75B7-47D3-8FF7-2D8AAC5E3B87 @default.
- Q60211784 P50 Q60211784-187171C6-9EE9-4A15-BF02-AFBDDCC7116C @default.
- Q60211784 P50 Q60211784-1A78FDF6-0C7F-48B2-807B-5ABBBE347150 @default.
- Q60211784 P50 Q60211784-5FA6B98C-45AC-4A2E-9FDD-8DF1280026B9 @default.
- Q60211784 P50 Q60211784-6B28D18E-5269-4DDB-AC4D-4E588755FC50 @default.
- Q60211784 P50 Q60211784-75C3FF45-47E0-47EF-A58E-87D3BC8E4077 @default.
- Q60211784 P50 Q60211784-7CFDEE42-A651-4FAA-8D2C-F74076A2EA45 @default.
- Q60211784 P50 Q60211784-975DF97B-893D-4C37-9308-B17BB065EF54 @default.
- Q60211784 P50 Q60211784-A0933CE9-809B-4E7D-9153-70D9E1CCA8AE @default.
- Q60211784 P50 Q60211784-A0B8BDA8-73E5-42EC-87A6-54CB796B05D5 @default.
- Q60211784 P50 Q60211784-A8373AEC-E267-4864-B4B6-C1A35F143EB7 @default.
- Q60211784 P50 Q60211784-E00E406B-B18C-499C-95AF-774AD87F85F2 @default.
- Q60211784 P577 Q60211784-5A108550-C33A-461B-80D2-C8F639C36F89 @default.
- Q60211784 P698 Q60211784-223907A3-2BAB-4B01-82EA-C82DACB2367D @default.
- Q60211784 P921 Q60211784-3BADA5A4-0B1C-4340-ACF8-B144DD7D4F8C @default.
- Q60211784 P921 Q60211784-FCD3616A-AA03-433F-B7BE-8EEEE5D4CC95 @default.
- Q60211784 P356 1535-7163.MCT-17-0733 @default.
- Q60211784 P698 29970484 @default.
- Q60211784 P1433 Q2363144 @default.
- Q60211784 P1476 "Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy" @default.
- Q60211784 P2093 "Piia-Riitta Karhemo" @default.
- Q60211784 P2093 "Reidar Grénman" @default.
- Q60211784 P2093 "Riku Louhimo" @default.
- Q60211784 P2093 "Tatiana Lepikhova" @default.
- Q60211784 P2860 Q28266682 @default.
- Q60211784 P2860 Q28288215 @default.
- Q60211784 P2860 Q29547693 @default.
- Q60211784 P304 "2060-2071" @default.
- Q60211784 P31 Q13442814 @default.
- Q60211784 P356 "10.1158/1535-7163.MCT-17-0733" @default.
- Q60211784 P433 "9" @default.
- Q60211784 P478 "17" @default.
- Q60211784 P50 Q117252465 @default.
- Q60211784 P50 Q125317558 @default.
- Q60211784 P50 Q125317677 @default.
- Q60211784 P50 Q16299408 @default.
- Q60211784 P50 Q29949182 @default.
- Q60211784 P50 Q31058683 @default.
- Q60211784 P50 Q41044826 @default.
- Q60211784 P50 Q42765702 @default.
- Q60211784 P50 Q56477121 @default.
- Q60211784 P50 Q58287084 @default.
- Q60211784 P50 Q60628877 @default.
- Q60211784 P577 "2018-07-03T00:00:00Z" @default.
- Q60211784 P698 "29970484" @default.
- Q60211784 P921 Q18554836 @default.
- Q60211784 P921 Q864574 @default.